Literature DB >> 22696700

Vincristine-induced unilateral ptosis with serendipitous response to modafinil.

Swaroop Revannasiddaiah1, Tapesh Bhattacharyya.   

Abstract

Here we describe a scenario of an atypical manifestation of vincristine-induced neurotoxicity, which responded serendipitously to modafinil. Atypical in that this patient had developed a uniocular ptosis, a rare manifestation of vincristine-induced neurotoxicity. The improvement in neurotoxicity after modafinil was started to alleviate morphine-induced sedation was quite noteworthy.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22696700      PMCID： PMC3089848          DOI： 10.1136/bcr.07.2010.3178

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  24 in total

Review 1.  Chemotherapy-induced peripheral neuropathy.

Authors:  Stefan Quasthoff; Hans Peter Hartung
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

2.  Mechanism of inhibition of cell proliferation by Vinca alkaloids.

Authors:  M A Jordan; D Thrower; L Wilson
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

Review 3.  Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.

Authors:  R H Himes
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

Review 4.  The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

Authors:  E K Rowinsky; R C Donehower
Journal:  Pharmacol Ther       Date:  1991-10       Impact factor: 12.310

5.  Modafinil augmentation of antidepressant treatment in depression.

Authors:  M A Menza; K R Kaufman; A Castellanos
Journal:  J Clin Psychiatry       Date:  2000-05       Impact factor: 4.384

6.  Walking with modafinil and its use in diplegic cerebral palsy: retrospective review.

Authors:  Daniel L Hurst; Walter A Lajara-Nanson; Margie E Lance-Fish
Journal:  J Child Neurol       Date:  2006-04       Impact factor: 1.987

7.  Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil.

Authors:  T M Engber; E J Koury; S A Dennis; M S Miller; P C Contreras; R V Bhat
Journal:  Neurosci Lett       Date:  1998-01-30       Impact factor: 3.046

8.  Use of modafinil in spastic cerebral palsy.

Authors:  Daniel L Hurst; Walter Lajara-Nanson
Journal:  J Child Neurol       Date:  2002-03       Impact factor: 1.987

9.  Glutamate ameliorates experimental vincristine neuropathy.

Authors:  F M Boyle; H R Wheeler; G M Shenfield
Journal:  J Pharmacol Exp Ther       Date:  1996-10       Impact factor: 4.030

10.  Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life.

Authors:  Milton K Erman; Russell Rosenberg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.